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Abstract
Background: An unknown input function can be determined by deconvolution using the systemic
bolus input function (r) determined using an experimental input of duration ranging from a few
seconds to many minutes. The quantitative relation between the duration of the input and the
accuracy of r is unknown. Although a large number of deconvolution procedures have been
described, these routines are not available in a convenient software package.
Methods: Four deconvolution methods are implemented in a new, user-friendly software program
(PKQuest, http://www.pkquest.com). Three of these methods are characterized by input
parameters that are adjusted by the user to provide the "best" fit. A new approach is used to
determine these parameters, based on the assumption that the input can be approximated by a
gamma distribution. Deconvolution methodologies are evaluated using data generated from a
physiologically based pharmacokinetic model (PBPK).
Results and Conclusions: The 11-compartment PBPK model is accurately described by either a
2 or 3-exponential function, depending on whether or not there is significant tissue binding. For an
accurate estimate of r the first venous sample should be at or before the end of the constant
infusion and a long (10 minute) constant infusion is preferable to a bolus injection. For noisy data,
a gamma distribution deconvolution provides the best result if the input has the form of a gamma
distribution. For other input functions, good results are obtained using deconvolution methods
based on modeling the input with either a B-spline or uniform dense set of time points.
Background
The deconvolution approach has become a commonly
used technique to determine the time course of a systemic
input (I(t)) to a linear system given the system response to
a known bolus intravenous (IV) input . This approach is
based on the following fundamental equation:
where r(t) is the systemic (e.g. venous) concentration that
is produced by a bolus systemic input of unit amount
("bolus response function"); I(t) is the unknown systemic
input rate (for example, from an oral dose); and c(t) is the
systemic (e.g. venous) concentration that is produced by
the unknown systemic input I(t). For example, if r(t) is the
venous concentration from a bolus IV injection of 1 g of
X, and c(t) is the venous concentration after the oral inges-
tion of X, then I(t) corresponds to the rate (in g/min) that
this oral dose of X reaches the systemic circulation. If there
is no liver metabolism of X, then I(t) is equal to the rate of
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intestinal absorption of X. If there is some liver metabo-
lism (i.e. first pass metabolism), then I(t) is a measure of
the systemic availability of X after an oral dose.
There are two separate problems that must be addressed
in order to find I(t). The first is the determination of bolus
input function r(t). This involves finding a continuous
function that provides a good approximation to r(t) given
the discrete set of venous concentrations determined, e.g.,
after a constant IV infusion. The second problem is, given
r(t), estimate I(t) using the discrete set of data points for
c(t).
While there is a voluminous literature that addresses the
second problem [1–13], little attention has been paid to
the first problem. The first part of this paper uses a physi-
ologically based pharmacokinetic model (PBPK) to ad-
dress the following two questions about this standard
approach:
1) It is usually assumed that r(t) can be approximated by
a 2 or 3 exponential function. The standard approach is to
fit experimental data with both a 2 and 3 exponential
function and use statistical tests to determine whether the
additional adjustable parameters have significantly im-
proved the fit, given the experimental error. From these
measurements one cannot separate errors in experimental
measurement from intrinsic limitations in the multi-ex-
ponential functional description of the system. It would
be desirable to test the ability of multi-exponential func-
tions to describe r(t) for error free data. In this paper, mul-
ti-exponential functions will be used to fit exact data
generated using a PBPK model that mimics the detailed
human pharmacokinetics. One would expect that a 2 or 3-
exponential function would only provide a crude approx-
imation to the complicated 11 compartment PBPK
model.
2) The bolus input function r(t) is determined by fitting
venous data produced by a known constant IV infusion.
The duration of this infusion can vary from a few seconds
(mimicking a "bolus" input) to 20 or more minutes. Ob-
viously, one would like to sample the venous concentra-
tion over the entire time course. However, because of
unavoidable circulatory and mixing time delays, venous
concentration measurements for time points earlier than
2 or 3 minutes are not reliable. The earliest experimental
venous concentration measurements that are used to de-
termine the bolus input function r(t) are often at 5 or 10
minutes and, in some cases, as long as 60 minutes [12].
Although it seems intuitively clear that, in order to avoid
the need for early time sampling, one should use an IV in-
fusion of relatively long duration, this question has not
been looked at quantitatively. In this paper, PBPK human
models will be used to quantitatively investigate the rela-
tionship between the duration of the constant IV infusion
and the venous sampling rate required for an accurate es-
timate of r(t).
The second part of this paper addresses the second prob-
lem in the determination of I(t) – how to solve for I(t)
once r(t) is known. Since this poses a challenging mathe-
matical problem, it has elicited a number of sophisticated
numerical solutions from a large number of investigators.
The following four fundamentally different approaches
are examined in this paper:
Gamma distribution Input
The use of a predetermined parametric function for I(t) is
the most direct approach. It is shown below that a good fit
to a variety of experimental intestinal absorption process-
es is provided by the 3 parameter (A,a,b) gamma
distribution:
(2)   I(t) = Abata-1 exp(-bt)/Γ(a)
where A is the total amount reaching the systemic circula-
tion, Γ is the gamma function, a is the gamma number
(usually between 1.0 and 6.0) and b has units of inverse
time. The gamma distribution is clearly superior to poly-
exponential functions for fitting the initial time delay in
absorption associated with gastric emptying. The use of a
gamma distribution to model absorption was first sug-
gested by Debord et. al. [2]. The 3 parameters are deter-
mined by the use of global (simulated annealing) and
local (Powell) non-linear optimization.
Analytical Deconvolution
In this approach, c(t) (eq. 1) is approximated by an inter-
polating or smoothed spline function and the deconvolu-
tion uses the analytic approach of Veng-Pedersen [14,15]
and Gilespie and Veng-Pedersen [3]. This approach is
used in the freely distributed program PCDCON written
by Gillespie http://anesthesia.stanford.edu/pkpd and is
the most widely used experimental deconvolution tech-
nique [16–21].
Spline Function Input
This method uses the approach of Verotta [4,5] in which
the input I(t) is parameterized by a general B-spline func-
tion and the deconvolution is obtained using constrained
regression.
Uniform Input
In this approach the function I(t) is estimated on a dense,
uniform sequence of time points and the stochastic regu-
larization procedure of De Nicolao et. al. [1] and Sparaci-
no et. al. [22,23] is used for the deconvolution.BMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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Since each of these approaches has been extensively de-
scribed and compared previously, what justifies the new
treatment in this paper? There are 3 new features:
1) The four above mathematical approaches to the decon-
volution problem are implemented in the software pack-
age PKQuest. This software has a simple user interface,
and automatically plots the results in a variety of formats.
This easy to use, freely distributed program http://
www.pkquest.com allows anyone to use and compare the
different approaches for different experimental data sets.
2) The last 3 approaches are characterized by a number of
user input parameters whose values are not known a pri-
ori. In the previous applications of these routines, these
parameters had to be varied and the "best" value found ei-
ther based on the subjective judgment of the user about
the "quality" of the fit, or by a semi-empirical optimiza-
tion procedure. This represents the major limitation of
these techniques. In this paper a new method is intro-
duced for determining the value of these parameters for
the last two methods ("Spline function" and "Uniform")
based on the use of a gamma distribution approximation
for I(t).
3) Previous tests of the different approaches have used ei-
ther idealized model data or experimental data in which
the true values of the bolus input function r(t) and the sys-
temic input function I(t) were not known. In contrast, in
the analysis described here, the different methods will be
tested using the same PBPK model that was used to deter-
mine r(t). In general, all the methods work well if accurate
experimental data are used (see below). The most strin-
gent test of the different methods is under conditions
when there is random error in the data points and sam-
pling frequency is limited, as is often the case for the ex-
perimental data. This latter case is investigated in this
paper.
Methods
Generation of PBPK Model Venous Concentration Data
The model venous concentration data for the intravenous
(IV) and intestinal input are generated using the PKQuest
http://www.pkquest.com PBPK software. The "standard
human" PBPK organ weights and blood flows are listed in
Table 1. These are the same values that have been used
previously to model the pharmacokinetics of D2O and
ethanol [24], toluene and the volatile anesthetics [25],
propranolol [26] and inulin and protein bound antibiot-
ics [27]. Two different PBPK models are used. In the first
model (referred to as "simple") the solute distributes with
flow-limited kinetics in all the body water and there is no
solute binding. In the second model (referred to as "bind-
ing") the different tissues bind the solute with a tissue/
plasma equilibrium partition coefficient of 10 for all tis-
sues except muscle (where it is 3.62) and fat (where it is
2.42). This model is similar to that used to describe hu-
man propranolol pharmacokinetics [26]. The model in-
put goes directly into the venous compartment, bypassing
the liver, and the solute clearance is produced entirely by
renal secretion so that the input function ("absorption"
rate) is equal to the systemic availability.
Determination of Poly-exponential Bolus Response 
Function
The standard approach is used for determining the bolus
response function r(t). It is assumed that r(t) is described
by a polyexponentials function:
Table 1: Organ Weights and Blood Flows for Standard Human (70 Kg, 20% Fat)
Organ Weight (Kg) Blood Flow (lit/min/Kg)
Artery 1.1 ----
Vein 4.4 ----
Liver 1.8 0.25 (hepatic artery)
Portal 1.5 0.75 (portal vein)
Kidney 0.31 4.0
muscle 33.0 0.0266
brain 1.4 0.56
heart 0.33 0.8
lung 0.536 14.98
skin 2.6 0.12
fat 14 0.056
"other" 4.12 0.054
"bone" 4.90. 0.0BMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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The optimum values for the parameters (ai, Ti) are deter-
mined by using the Maple implementation of the non-lin-
ear Levenberg and Marquardt method (nlfit, http://
www.math.villanova.edu/archives/maple/misc). Some
care must be used in the application of this technique be-
cause, if the initial estimates of ai and Ti are far from the
correct values then, for the 3-exponential case, it is possi-
ble for the solution to become stuck in a local minimum,
far from the global minimum. In the implementation in
PKQuest, a 2- exponential fit is found first, and this fit is
used to estimate the initial values for the 3-exponential fit.
This procedure seems to be quite robust.
Gamma distribution Deconvolution
It is assumed that the input function can be described by
a 3 parameter (A,a,b) gamma distribution (eq. 2). The 3
parameters are chosen by minimizing the error function:
where the sum is over all the data points, ydati is the ex-
perimental venous concentration, and ygami is the venous
concentration determined by convoluting the gamma dis-
tribution input (eq. 2) with the polyexponential bolus re-
sponse function r(t) (eq. 3). The parameter "noise"
determines the relative weighting of each data point. If
noise = 0, then the error is proportional to the sum of the
fractional error ((ygam-ydat)/ydat) of each point, while
for noise>>ydat, the error is proportional to the sum of
the absolute error (ygam-ydat) of each point. In the cur-
rent implementation, noise is assumed to be equal to 10%
of the value of average venous concentration (ydati). Since
the convolution of the gamma distribution with r(t) is a
highly non-linear function, it is essential to use a robust
optimization procedure to avoid local minimums. In the
implementation in PKQuest, a global annealing proce-
dure [28] is applied first, followed by Powell [29] non-lin-
ear minimization.
Analytical Deconvolution
The approach described originally by Veng-Pederesen
[14,15] is followed. The discrete venous concentration
data (c [i], eq. 1) is fit with either an interpolating (which
goes through each data point) or a smoothing cubic spline
function, and then the deconvolution is obtained analyti-
cally using this spline function. The spline fitting algo-
rithms of Spath [30] were used for both the interpolating
("cub2r7") and smoothing ("cubsm1") conditions. In the
smoothing algorithm the spline points differ from the ex-
perimental data points by an amount that is proportional
to the jump in the third derivative of the cubic spline func-
tion. The proportionality constant is assumed to be the
same for each data point and is set by a user input
"smoothing parameter" that varies from 0 (interpolating
case) to infinity. This implementation is not identical to
that used in program the PCDCON written by W. R.
Gillespie http://anesthesia.stanford.edu/pkpd. However,
when the same input was used for PCDCON and the cur-
rent implementation, the results were very similar.
Spline Function Deconvolution
The deconvolution approach of Verotta [5] is used. The in-
put function I(t) is parameterized by a B-spline function
characterized by the number and position of the "break-
points" and the order of the spline function. An order of
3 is assumed. The deconvolution is obtained using the
"Penalized Least_Squares" regularization approach [5],
where the regularization parameter (referred to here as a
"smoothing parameter") limits the roughness of the B-
spline function. The input rate I(t) is constrained to non-
negative values by using the constrained conjugate gradi-
ent algorithm (11.4) of Hestenes [31].
The quality of the deconvolution solution is critically de-
pendent on the number and position of the break points
(see Results Section). In the implementation in PKQuest,
a number of alternative options are allowed for choosing
or inputting the break points. Since this method is a gen-
eralized parametric approach, one would like to use the
smallest number of breakpoints (and, therefore, the
fewest adjustable parameters) that are compatible with
the input function. A new feature that is introduced here
is the use of the gamma distribution input approximation
to automatically select the breakpoints (this is the default
option in PKQuest). This method first chooses the break-
points that provide a good fit to the gamma distribution,
and then supplements these breakpoints with additional
points (at 1 hour intervals) at long times when the gamma
distribution is small. By trial and error it was found that
the minimum number of break points that provided a
good fit to the gamma distribution were located at the
times the gamma distribution concentration equaled
0.05, 0.7, 1, 0.55, 0.1 and 0.0012 times the maximum
gamma distribution value. As shown in the Results Sec-
tion, this procedure works well for the typical intestinal
absorption input functions.
Uniform Input Deconvolution
The method of De Nicolao et. al. [1] which solves for the
values of the input function on a uniform, dense set of
time points is used. Only the constrained option [1] is
used since it is essential to limit the input function to non-
negative values. De Nicolao et. al. [1] describe a
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sophisticated mathematical approach using the fast fouri-
er transform (FFT). However, in the implementation in
PKQuest (using Maple) it was observed that the overhead
required to set up the FFT approach used more CPU time
than the more direct implementation that was finally
adopted.
This approach is critically dependent on the "regulariza-
tion" parameter (referred to in this paper as "smoothing
parameter") and De Nicolao et. al. [1] described a number
of criteria for choosing the "best" value of this parameter.
In PKQuest, a new option is introduced that uses the gam-
ma distribution input function to obtain a default value of
the smoothing parameter. The error function that is min-
imized to determine the input vector U is the sum of two
terms [1]:
(5)   Error Function = (Y - GU)T (Y - GU) + γUT (FT F)U
In the first term the matrix (Y-GU) is a measure of the er-
ror difference between the experimental venous concen-
trations (Y) and the model values given by the
convolution of the input vector (U) and bolus input func-
tion operator (G). The second term is a measure of the
roughness of the data where γ is the smoothing parameter
and F is the second difference matrix. The new procedure
that is used to estimate the smoothing parameter (γ) is to
set the input vector U equal to the approximate gamma in-
put function and solve for the value of γ that makes the
two terms in eq. 5 have equal weight. This calculation of γ
is limited to time points where the value of the gamma
distribution is greater than 1% of the peak value of the
gamma distribution – that is, points where the gamma
distribution provides a good approximation. Although
this choice of equal weights is empirical and was based on
trial and error on one set of data, it seems to work well for
a large range of experimental data, even when the actual
input differs significantly from a gamma distribution (see
Results Section).
PKQuest Implementation: User Interface and Graphical 
Output
All the deconvolution procedures and the software code
used in this paper are freely available on the web http://
www.pkquest.com. The complete deconvolution proce-
dure is called by a short Maple worksheet. One simple ex-
ample is shown below:
sample_deconv:proc()
# The following ivinput is for a 10 minute IV infusion of 1000
micromoles ninput:1;
ivinput[1]:table([type = 1,amount = 1000,tbeg = 0,tend =
10]);
# Venous concentration data [time, conc] resulting from above
IV input:
ivdata: [0.000,0.0000], [2.500,18.3743],
[5.000,20.0258],[10.000,22.137
9], [15.000,4.1428]; [20.000,3.9987], [25.000,3.8501],
[30.000,3.6699], [60.000,2.6839], [90.000,2.1099],
[120.000,1.7697], [180.000,1.3768], [300.000,.9629],
[480.000,.6157], [720.000,.3499]];
# Venous concentration data following an unknown input
absdata: [0.000,0.0000], [2.500,.0001], [5.000,.0016],
[10.000,.0223],[1
5.000,.0909], [20.000,.2265], [25.000,.4339],
[30.000,.7055], [60.000,2.7337], [90.000,3 .6826],
[120.000,3.4554], [180.000,2.2889], [300.000,1.2593],
[480.000,.7631],
[720.000,.4298]];
deconvolution:table([usedata = 3,fitfunc = 2,plotinput =
1,Nexp = 3,breakpoint = 5, scale_smooth= 1]);
convolve(writedir,cunit,ivinput,ivdata,absdata,syspar,gamm
apar,gammaparmod, deconvolution);
end proc:
The amount and time course of the IV input that is used
for the calculation of the bolus response function r(t) is
characterized by the Maple table ivinput. The venous con-
centration data is described by the parameters ivdata (used
to determine r(t)) and absdata (venous concentration re-
sulting from unknown input). The data can also, option-
ally, be read in from a data file. The parameter
deconvolution is a Maple table characterizing the type of de-
convolution calculation: usedata determines whether the
bolus response function, the input function, or both func-
tions are found, fitfunc  determines the deconvolution
technique that is used, plotinput  specifies the graphical
output, Nexp is the number of exponentials in the bolus
response function, breakpoint is either the type of proce-
dure used to determine the breakpoints for the spline de-
convolution, or the time interval for the uniform
deconvolution and scale_smooth scales the smoothing pa-
rameter. The deconvolution procedure is run by the call to
the convolve() procedure. In addition to the above param-
eters, a number of optional parameters can be entered:
writedir is the directory where the input function is writ-
ten, cunit (e.g = "micromoles") is the amount unit used in
the output plots, gammapar  and  gammaparmod  are the
gamma parameter input and model function parametersBMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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and  syspar  is the bolus response function parameters
(these 3 inputs are optional, depending on the type of cal-
culation and graphical output). Sample deconvolution
procedures and a detailed Manual and Help pages can be
downloaded from the PKQuest web site.
When the above procedure is run, a large number of dif-
ferent graphical plots are output. The calculations of the
bolus response function r(t) are routinely described by the
following four plots that compare the venous concentra-
tion determined from r(t) versus the experimental data:
1)the early time points, 2) the late time points, 3) a semi-
log plot of all the time points, and 4) all the time points.
Three of these plots are shown in figs. 2 to 9. Three differ-
ent statistical tests are applied to the r(t) calculation so
that the user can determine whether a 2 or 3 exponential
function should be used [32].
The deconvolution calculation of the unknown input
function I(t) is routinely described by the following three
plots: 1) Plot of the calculated I(t) versus time, along with
a comparison with the gamma distribution deconvolu-
tion (optional) and the model gamma distribution input
(optional), 2) Comparison of the calculated deconvolu-
tion venous concentration with the experimental data,
and 3) Plot of the total amount of absorption versus time.
Examples of plots #1 and #2 are shown in figs. 9 and 10.
In addition, if writedir is specified, then a text file describ-
ing I(t) is written. All of the plots shown in this paper are
copied directly from the standard PKQuest output.
Detailed Description of Deconvolution Data Test Sets
The tests of the deconvolution procedure in this paper are
based on two sets of data: one with a single gamma distri-
bution input and one with this same gamma distribution
plus a delayed, smaller gamma distribution input. In this
section a detailed description of these data sets is provided
so that other investigators can use this data as deconvolu-
tion test cases.
For both sets of data the system unit bolus response func-
tion was:
(6)   r(t) = 0.259e-1.466t + 0.00188e-0.00235t + 0.00287e-
0.0184t
The single input was a gamma distribution (eq. 2) with A=
1 mm; a = 4.85; b = 0.0534 min-1 that started at time = 0.
For the two input case a second gamma input was added
with A = 0.2 mm; a = 4.85; b = 0.0269 min-1 that started
at t = 120 minutes. For the single input, the data was sam-
pled at 10, 20,30,60,90,120,180,300,480 and 720 min-
utes. The exact venous concentration (micromole/liter)
data for the single input at these times was: 0.0223,
0.2265, 0.7055,2.7337,3.6826, 3.4554, 2.2889, 1.2593,
0.7631, 0.4298. The corresponding data for the three
noisy data sets was: Noisy #1: 0.0277, 0.1263, 0.8041,
2.7568, 3.1491, 3.9856, 2.0443, 1.2508, 0.7204, 0.3856;
Noisy #2: 0.0216, 0.1794, 0.6865, 2.664, 3.643, 2.966,
1.891, 0.8765, 0.7297; Noisy #3: 0.0743, 0.1469, 0.8238,
2.6195, 4.3413, 2.9676, 2.628, 1.224, 0.8350, 0.4913.
The two input data was sampled at 10, 20, 30, 60, 90, 120,
180, 240,300, 360, 420, 480 and 720 minutes. The exact
venous concentration data at these times was
0.0223,0.2265,0.7055, 2.7337,3.6826, 3.455, 2.374,
1.957,1.751, 1.511, 1.270, 1.066, 0.5747. The corre-
sponding data for the three noisy data sets was: Noisy #1:
0.029, 0.1572, 0.7951, 2.777, 3.1268, 3.9608, 2.1788,
1.981,1.567, 1.313, 1.294, 1.166, 0.6495; Noisy #2:
0.0395, 0.356, 0.6521, 2.495, 3.587, 2.9813, 2.0294,
1.4484, 1.705, 1.4749, 1.0513, 1.1566, 0.4995; Noisy #3:
0.0613, 0.1311, 0.8173, 2.6478, 4.287, 2.998, 2.721,
1.881, 1.971, 1.9528, 1.3802, 1.2038, 0.6266.
Results
Use of a gamma distribution to describe the rate of intes-
tinal absorption
In PKQuest, a recently introduced PBPK software routine,
a new approach is introduced that provides a direct meas-
ure of the rate of intestinal absorption of a solute if the
PPBK parameters are known. Figure 1 shows the result of
applying this technique to experimental data for three dif-
ferent solutes in humans: ethanol [24] (with or without a
meal), standard propranolol [26] and a long acting form
of propranolol [26]. The squares in these figures describe
the time course of the total absorption as determined by
PKQuest. The solid line is the gamma distribution fit (eq.
2) to the squares. It can be seen that in all cases the 3-pa-
rameter gamma distribution provides a good fit to the ex-
perimental data. The standard propranolol absorption
rate (fig. 1, lower left panel) has a long initial time delay
followed by a steep rise – a time course that is especially
difficult to fit with other functions (e.g. exponential, Hill
equation) but is closely fit by the gamma distribution. For
this reason, the gamma distribution has been chosen in
this paper as the function of choice to model intestinal ab-
sorption data. It also provides a good fit to absorption
from other sites, e.g. skin, intramuscular and
intraperitoneal.
Use of a PBPK Model to Evaluate the Accuracy of the De-
termination of the Bolus Input Function r(t)
The accuracy of the determination of r(t) will be evaluated
2 different ways. In the first test, a continuous venous con-
centration curve will be generated using a known constant
IV input to the PBPK model. This continuous curve will
then be sampled at varying discrete time points which will
be used to determine r(t). Comparing the venous concen-
tration curve determined using this r(t) with the original
PBPK venous data provides a direct test of the accuracy ofBMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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Figure 1
Gamma distribution fit to intestinal absorption rate. The absorption rates were determined by applying PKQuest to experi-
mental measurements of venous concentrations after an oral dose of ethanol (fasting or with a meal), standard propranolol or 
long acting propranolol. The open squares are the experimental data points and the solid line is a 3-parameter gamma distribu-
tion fit to these points.
Gamma Function Fit to Measurements of Intestinal Absorption
Ethanol - Fasting
Ethanol - Meal
Standard Propranolol
Long Acting Propranolol
MinutesBMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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Figure 2
"Simple" PBPK model with exact data sampled at high resolution. Accuracy of 2-exponential bolus input function determined 
using model venous concentration data generated using the "simple" PBPK organ model. The data was sampled (black squares) 
at the "high resolutions" time points (2.5, 5, 10, 15, 20, 25, 30, 60, 90, 120, 180, 300, 480 and 720 minutes). The left hand col-
umn shows the results for the case where a 30-second constant infusion IV infusion was used. The right hand column results 
are for a 10-minute constant IV infusion. The first 3 columns compare the model venous concentration (black) with the con-
centration determined using the bolus input function (red). The first row is for short times, the second for long times and the 
third is a semi-log plot for all times. The last row compares the deconvolution intestinal input rate (black) with the model input 
rate (green).
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Figure 3
"Simple" PBPK model with exact data sampled at low resolution. Same as figure 2 except the data was sampled at the "low" 
resolution time points (10, 20, 30, 60, 90, 120, 180, 300, 480 and 720 minutes).
Simple PBPK Model -Low Resolution Exact Data
2 Exponential Response Function
30 Second Constant Infusion 10 Minute Constant Infusion
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Figure 4
"Binding" PBPK model with exact data sampled at high resolution. Same as figure 2 except that the "binding" PBPK organ model 
was used to generate the model data.
Binding PBPK Model -High Resolution Exact Data
2 Exponential Response Function
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Figure 5
"Binding" PBPK model with exact data sampled at low resolution. Same as figure 4 except the data was sampled at the "low" 
resolution time points.
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Figure 6
"Binding" PBPK model with exact data sampled at high resolution using 3-exponential response function. Same as figure 4 
except that a 3-exponential bolus response function was used.
Binding PBPK Model -High Resolution Exact Data
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Figure 7
"Binding" PBPK model with exact data sampled at low resolution using 3-exponential response function. Same as figure 6 
except the data was sampled at the "low" resolution time points.
Binding PBPK Model -Low Resolution Exact Data
3 Exponential Response Function
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Figure 8
"Binding" PBPK data for 30 minute constant infusion with first data point at 30 minutes.
Binding PBPK Model -High Resolution Exact Data
3 Exponential Response Function - 30 Minute Constant Infusion
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Figure 9
Evaluation of the "gamma distribution" deconvolution method for "noisy" data. The green line (left column) shows the gamma 
distribution intestinal input to the "binding" PBPK model. The PBPK model venous concentration produced by this input was 
made "noisy" by adding a normally distributed random error (black squares, right column) and these data points were then 
used to determined an intestinal input rate (black line) and the corresponding venous concentration (red line) using the gamma 
distribution deconvolution method. Each row shows the results for a different set of random data.
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r(t). In the second test, this r(t) will be used to calculate
I(t) by applying eq. 1 to the venous concentration data
produced by a known gamma distribution input to the
same PBPK model. Comparison of the deconvolution I(t)
versus the actual model input provides another indication
of the accuracy of r(t). The model intestinal input gamma
distribution parameters are similar to the absorption pa-
rameters for the standard propranolol shown in fig. 1 (A
= 1 millimole; a = 4.85; b = 0.0534 min-1).
The results will be presented for the two different PBPK
models: a) the solute distributes in all the tissue water
with no tissue binding (referred to as "simple" model);
and b) there is tissue binding of the solute, similar to what
is observed for propranolol (referred to as "binding" mod-
el) (see Methods section for a detailed description). In
both models, it is assumed that the solute clearance is pro-
duced only by renal secretion and the model input is di-
rectly into a systemic vein.. Results will be shown for a 2
or 3 exponential response function for venous concentra-
tion data sampled at "high" resolution (2.5, 5, 10, 15, 20,
25, 30, 60, 90, 120, 180, 300, 480 and 720 minutes) and
"low" resolution (10, 20, 30, 60, 90, 120, 180, 300, 480
and 720 minutes). The first time point for the high reso-
lution data is at 2.5 minutes and, considering the experi-
mental mixing and delay artifacts, one probably cannot
expect to be able make accurate measurements at times
before this. For each case, the results of a 10-minute con-
stant infusion will be compared with a 30-second con-
stant infusion. The 30-second infusion is meant to mimic
an experimental "bolus" input.
Figures 2 to 8 quantitate the accuracy of the determination
of the bolus response function r(t) under various condi-
tions. In each figure, the black line is the exact model ve-
nous concentration resulting from either a 30-second (left
column) or 10-minute (right column) constant IV infu-
sion into the PBPK model system. The black squares are
the discrete venous concentration data points that were
used to determine r(t). The red lines in these figures are
the venous concentration curves resulting from convolu-
tion of the calculated bolus response function r(t) with
the model input function. The first row shows the fit for
the early time points; the second row for the long time
points, and the third row is a semi-log plot for all the data.
The bottom row compares the true model intestinal gam-
ma input function (green) with the intestinal input rate
determined by the gamma distribution deconvolution
method (see below) using this r(t) (black).
Figures 2 and 3 show the results for the "simple" PBPK
model using a 2-exponential bolus input function r(t) for
the high (fig. 2) and low (fig. 3) time resolution data. For
a 10-minute constant IV infusion (right column, figs. 2
and 3), the venous concentration calculated using the 2-
expononential r(t) (red line) provides a good fit to the en-
tire time course of the model venous concentration (black
line). As expected for this good estimate of r(t), the decon-
volution intestinal absorption rate determined using this
r(t) (bottom row, black line, right column) is very close to
the true, model input function (green line).
For the 30-second constant infusion (left hand column)
there is a sharp early spike in the venous concentration
which must be fit by extrapolation of the venous data
points back from the first data point at either 2.5 minutes
(high resolution, fig. 2) or 10 minutes (low resolution, fig.
3). In each case, this extrapolated venous concentration
(red line) is a poor approximation to the true model ve-
nous concentration (black). The bottom row in these fig-
ures quantitates the influence of this early time error on
the determination of the intestinal absorption rate by de-
convolution by comparing the model rate (green) versus
the deconvolution rate (black). It can be seen that for this
"simple" model the error in the deconvolution intestinal
absorption rate is quite small, despite the large early error
in the venous concentration.
Figures 4 to 8 show a similar set of results for the "bind-
ing" PBPK model. The tissue binding increases the volume
of distribution and results in a more "complicated"
venous concentration time course. One indication of this
"complicated" times course is that a 2-exponential bolus
response function r(t) no longer provides an accurate de-
scription of the venous concentration for the high resolu-
tion exact data (fig. 4, right column). In contrast, a 3-
exponential r(t) provides a nearly perfect fit (fig. 6). Sur-
prisingly, despite the poor fit to the venous data using the
2-exponential r(t) for the 10 minute infusion, the intesti-
nal absorption rate (fig. 4, bottom row, right) determined
by deconvolution using this r(t) is in good agreement
with the model input (green).
For the 30-second constant infusion using the binding
model (left hand column, figs. 4 to 8), the venous
concentration predicted using r(t) for the times preceding
the first experimental time point (2.5 minutes for high
resolution, 10 minutes for low resolution) differs marked-
ly from the true, model venous concentration. The
corresponding error in the intestinal absorption rate is
small when the first data point is at 2.5 minutes (high res-
olution data, figs. 4 and 6), but becomes large when the
first point is at 10 minutes (low resolution data, figs. 5
and 7).
For the 10-minute constant infusion, an accurate determi-
nation of both the bolus response function and the input
can be obtained when the first venous sample is at 10
minutes (fig. 7, right column). This illustrates the impor-
tance of adjusting the sample times to the IV inputBMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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conditions. Figure 8 shows a similar result for a 30-minute
constant infusion with the first sample point at 30 min-
utes. This suggests, as a general rule, that an accurate de-
termination of the response function only requires that
the first sample point be obtained at or before the end of
the constant infusion.
It is clear from these results that one cannot judge the ac-
curacy of the response function from the agreement be-
tween the model (i.e. experimental) data points (squares)
and the calculated venous concentration using this re-
sponse function. For example, the poorest fit to the intes-
tinal absorption function is for the low resolution, 30-
second input (fig. 5, left column), even though there is
nearly perfect agreement between the data points and the
predicted venous concentration using the 2-exponential
r(t). The error results from the incorrect predicted venous
concentrations for the times preceding the first data point
at 10 minutes.
Evaluation of Deconvolution Procedures
In this section the four different techniques described in
the background section will be used to determine the in-
testinal absorption function I(t) by deconvolution (see
eq. 1). The accuracy of the different methods will be tested
by the use of a known intestinal input to the PBPK model
to generate the absorption venous concentration data. The
I(t) determined by deconvolution of eq. 1 using this data
and the previously determined bolus input function r(t)
will then be compared with the actual model input.
Results will be shown only for the "binding" PBPK model.
The bolus input function r(t) used in this section is the 3
exponential function determined for the "binding" PBPK
model using a 10 minute constant IV infusion and the
high resolution venous sampling. Since this r(t) provides
a nearly perfect kinetic description of this system (see fig.
6, right column), any errors in the intestinal input func-
tion I(t) must result from the deconvolution procedure.
The deconvolution procedures will first be tested for an
intestinal input rate described by the same gamma distri-
bution used above for figs. 2,3,4,5,6,7,8 (gamma distribu-
tion parameters: A= 1 millimole; a = 4.85; b = 0.0534 min-
1). In order to evaluate the deconvolution methods for a
more general input function that cannot be described by
a single gamma distribution, the procedures will also be
tested for the case where the input consists of two distinct
gamma distribution, a large standard input and an addi-
tional smaller, delayed component. This input mimics the
case of an intestinally absorbed solute that is excreted by
the liver and then reabsorbed (enterohepatic circulation).
Only the "low resolution" time points (10, 20, 30, 60, 90,
120, 180, 300, 480 and 720 minutes) will be used in this
section. The "high resolution" time points used above do
not improve the estimate of the absorption rate since the
additional points are at early times before any significant
absorption occurs. Although these "low resolution" time
points are quite sparse, they are representative of the lim-
ited sampling rate that is experimentally available.
Gamma distribution Input Deconvolution
This is the approach that was used above in figs.
2,3,4,5,6,7,8 (bottom row) to determine the intestinal ab-
sorption function. As shown in those figures, when an ac-
curate bolus response function r(t) was used (e.g. fig. 6),
this method returned a nearly perfect fit to the model in-
put function. This is not surprising since the model input
was also a gamma distribution. Figure 9 shows another
test of this deconvolution method using "noisy" venous
concentration data. The noisy data is generated by adding
random noise to each venous concentration data point (c
[i], eq. 1) generated using the gamma distribution input
to the "binding" PBPK model:
(7)   c[i] = c[i] + R[i] * c[i] + Noise[i]
where R [i] and Noise [i] are normally distributed random
variables with a mean of 0 and standard deviations of 0.1
and 0.05 millimoles/liter, respectively. This adds a ran-
dom error of 10% to each point and an additional abso-
lute noise with a mean error of 0.05 millimoles/liter.
Each row in fig. 9 shows the results for a different set of
random noisy data. The left hand column compares the
deconvolution intestinal absorption rate (black line) with
the model input rate (green line). The right hand column
compares the corresponding deconvolution based venous
concentrations (red line) with the "noisy" data points
(squares) that were used to calculate the deconvolution
input. The calculated intestinal absorption rate provides a
good approximation to the actual input for each noisy
data set. The total intestinal absorption calculation from
the deconvolution varies from 0.863 (middle row) to
1.089 (bottom) compared to the actual input of 1
millimole. This approach is inherently robust since there
are only 3 adjustable parameters and the shape must be a
gamma distribution.
Analytical Deconvolution
In this approach, the venous concentration data are fit
with a spline function, which is then used for an analytical
deconvolution. The spline fit can either be an exact inter-
polated fit that passes through each data point, or a
smoothed fit that limits the degree of curvature allowed in
fitting the points (see Methods for details). This latter case
is essential when fitting noisy data. In the implementation
of this method in PKQuest, the user sets a "smoothing"
parameter that varies from 0 (interpolating spline) to in-
finity. The parameter has been scaled so that, for each de-
convolution method, a value of smoothing = 1 provides a
good first estimate.BMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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Figure 10 shows the result of applying this approach to the
exact venous data for 4 different values of smoothing. Us-
ing an interpolating spline (smoothing = 0) provides a
nearly perfect fit to the model data. For smoothing values
of 1 or greater, the deconvolution results differ significant-
ly from the model data. Despite the error in the shape of
the curve, the deconvolution estimate of the total
absorption remains accurate. For example, for the
smoothing = 3 curve, the total calculated absorption is
1.013 compared to model input of 1 millimole.
Figure 11 shows the analytical deconvolution results us-
ing the same 3 sets of noisy data that were used in fig. 9
for the gamma input deconvolution method. Each panel
in fig. 11 compares the intestinal input rate determined by
this method (black) with the exact model input intestinal
absorption rate (green) and the rate determined by the
gamma input method in fig. 9 (red). Each column in fig.
11 is for one set of noisy data, and the results for 3 differ-
ent values of the smoothing parameter are shown in the 3
rows. The "best" fits for the three sets (columns) of noisy
data are for a smoothing parameter of 3 (first column),
0.1 (second column) and 1 (third column), although this
choice is clearly subjective. This figure illustrates that for
this method the intestinal absorption rate may have non-
physical negative values. (The negative region decreases as
the smoothing parameter is increased). This is one of the
major limitations of this approach. The other 3 methods
can be constrained (see Methods for details) to prevent
this.
Spline Function Input
This method uses the approach of Verotta [4,5] in which
the input is parameterized by a general B-spline function
and the deconvolution is obtained using a constrained re-
gression method that prevents the input rate from having
negative (non-physical) values. There are two sets of user
input adjustable parameters for this method: the choice of
the time "breakpoints" for the B-spline function, and the
value of the smoothing parameter that "penalizes" the fits
that have too sharp a curvature (see Methods for details).
As was the case for the gamma distribution and analytical
deconvolution techniques, this method also returns a
nearly perfect fit to the model data when applied to the ex-
act data (not shown).
Figure 12 shows the results of the application of this de-
convolution method to one of the noisy data sets used in
fig. 9 (first row) and fig. 11 (first column). The two
columns in fig. 12 correspond to the results for two differ-
ent sets of breakpoints and the different rows are for dif-
ferent values of the smoothing parameter. These results
show the critical dependence of this method on the choice
of time points used for the breakpoints. The excellent fit
on the left uses breakpoints at 0, 14, 42, 68, 115,173, 290,
400 and 720 minutes. The poor fit on the right has 2 ad-
ditional breakpoints, at 90 and 140 minutes.
The choice of time points for the good fit in the left col-
umn of fig. 12 is based on the application of the new
approach introduced here. If one knows, a priori, that the
absorption rate approximates a gamma distribution, then
the spline break points can be chosen to provide an
optimal fit to this gamma distribution (see Methods for
details). In the implementation of the spline function ap-
proach in PKQuest, there are a number of options for
choosing the breakpoints. One of these options is based
on first finding the gamma distribution approximation to
the intestinal absorption (fig. 9) and then using this func-
tion to select the break points.
The left hand column in fig. 12 also illustrates that, if this
optimal set of breakpoints is used, the quality of the fit is
relatively independent of the value chosen for the
smoothing parameter. This is a major advantage of this
approach because it means that an accurate estimate of
the intestinal absorption can be obtained using the de-
fault set of parameters, without any subjective user
decisions.
Figure 13 shows the fit using this default set of break-
points (using the gamma distribution approximation)
and smoothing parameter ( = 1) for the same 3 noisy data
sets that were used for the analytical (fig. 9) and spline
function (fig. 11) deconvolution methods. The intestinal
absorption rate determined using this approach is as good
as the gamma distribution approach. This may not sur-
prising since the gamma distribution has been used to
choose the break points. A better test of this approach to
choosing the breakpoints is described below where an in-
put that is clearly not a gamma distribution is used.
Uniform Input
In this approach the intestinal absorption function is de-
termined on a uniform, dense sequence of time points
and the stochastic regularization procedure of Nicolao et.
al. [1] and Sparacino et. al. [22,23] is used for the decon-
volution. This approach also constrains the solution so
that the input rate cannot be negative. In this approach
one solves for the concentration at many more time
points then there are data points and the system is highly
underdetermined. The system becomes solvable by
adding a constraint on the smoothness ("regularization")
of the solution. This means that the solution is strongly
dependent on the user input "smoothing parameter"
which can vary over a wide range depending on the time
interval, number of points and experimental data. This is
the main limitation of this approach. De Nicolao et. al. [1]
have discussed several different criterion for choosing the
"best" value of this parameter. These criteria are quite CPUBMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
Page 19 of 29
(page number not for citation purposes)
Figure 10
Evaluation of the "analytical" deconvolution method for exact data. Same as figure 9 except that the "analytical" deconvolution 
method was used and applied only to the exact venous concentration data (squares). Each row corresponds to a different ana-
lytical deconvolution smoothing parameter.
Analytical Deconvolution - Exact Data
Intestinal Absorption Rate
: Model Input
: Deconvolution
Venous Concentration
Smoothing = 0
Smoothing = 0.1
Smoothing = 1
Smoothing = 3BMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
Page 20 of 29
(page number not for citation purposes)
Figure 11
Evaluation of the "analytical" deconvolution method for "noisy" data. Comparison of intestinal input rate determined by "analyt-
ical" deconvolution (black line), "gamma distribution" deconvolution (red line) and the PBPK model input (green line). Each col-
umn is for a different noisy data set, and each row is for a different value of the analytical deconvolution smoothing parameter.
Analytical Deconvolution: Intestinal Absorption - Noisy Data
Model Gamma Analytical
Smoothing = 0.1
Smoothing = 1
Smoothing = 3BMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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Figure 12
Importance of choice of "breakpoints" on "spline function" deconvolution. Comparison of intestinal absorption rate deter-
mined by the "spline function" deconvolution method (black line) with the PBPK model input (red line) for one set of "noisy" 
data. The two columns correspond to different sets of B-spline "breakpoints" and the rows are for different value of the spline 
deconvolution smoothing parameter.
"breakpoints" = 0,14,42,68,115,173,290,400,720 "breakpoints" = 0,14,42,68,90,115,140,173,290,400,720
Spline Function Deconvolution - Intestinal Absorption - Noisy Data
Model Spline Function
S m o o t h i n g=0
Smoothing = 1
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Figure 13
Evaluation of the "spline function" deconvolution method for "noisy" data. Same as figure 9 except that the "spline function" 
deconvolution method was used. The "default" breakpoints and smoothing parameters were used for each noisy data set 
(rows). The red line (left column) is the gamma distribution deconvolution rate and is identical to the black line in fig. 9.
Spline Function Deconvolution - Noisy Data
Intestinal Absorption
Venous Concentration Model
Gamma
SplineBMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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intensive because they involve the repeated determination
of the fits for a large number of different values of the
"smoothing parameter" and then using statistical tests to
select the "best" value. In this paper a new, simpler, ap-
proach is used to estimate the value of this smoothing
parameter, again based on the assumption that the intes-
tinal absorption rate can be approximated by a gamma
distribution (see Methods for details). Another user ad-
justable parameter for this method is the unit time inter-
val tdel (the corresponding time points where the
solution is obtained are at 0, tdel, 2*tdel, 3*tdel....). There
are several constraints on the choice of tdel. This interval
should be a common divisor of all the experimental time
points, so that the experimental points fall on the uniform
time grid. The implementation in PKQuest rounds the ex-
perimental points to the nearest uniform point and, if the
rounding only amounts to a few percent, the error will be
negligible. The other constraint on the time points is that
the CPU time for the constrained, non-negative, solution
in the PKQuest implementation scales roughly as the
square of the number of time points and, thus, CPU time
constraints limit the size of the time interval. Since solute
absorption is, in general, a slowly varying and smooth
process, relatively long time intervals can be used and this
latter constraint is not usually limiting.
Figure 14 shows the intestinal absorption rate determined
with this approach for the exact data and the same 3 noisy
data sets that were used in figs. 9, 11 and 13. (A time in-
terval of 5 minutes was used for these results). The values
of the intestinal absorption rate determined by this meth-
od at the uniform set of time points (open squares) is
compared with the model input (green) and gamma dis-
tribution deconvolution result (red). All the fits use the
default smoothing parameter determined from the gam-
ma distribution fit to this same data (fig. 9). Although the
fit is very good for the exact data using this default
smoothing parameter, a better (nearly perfect) fit to the
model rate is obtained (not shown) using a smaller (1/10)
smoothing parameter. For the 3 noisy data sets, the de-
fault value corresponds to the "best" fit. Although the
intestinal absorption rate determined with this method
for the first noisy data set is slightly worse than the other
methods, the fits for the other 2 noisy sets is as good, or
better, than the other methods (compare figs. 9, 11 and
13).
Two Component Intestinal Input – Comparison of Differ-
ent Deconvolution Methods
In this section a more complicated model intestinal input
function is used in which a small delayed component is
added to the major component. The major component is
started at zero time and is a gamma distribution that is
identical to that used in figs. 9,10,11,12,13,14 (A = 1 mm;
a = 4.85; b= 0.0534 min-1). The second component is a
gamma distribution that has parameters: A= 0.2 milli-
moles; a = 4.85; b= 0.0269 min-1 and that begins at time
= 120 minutes. This second component has a total input
of 0.2 millimoles, 20 % of the major input, and a time
course that is spread over twice the time of the major in-
put. The venous concentration for this 2 input case is
sampled at three additional time points (at 240, 360 and
420 minutes) in order to resolve the delayed absorption
(time points = 10, 20, 30, 60, 90, 120, 180, 240,300, 360,
420, 480 and 720 minutes). This input mimics the situa-
tion of an orally administered drug that is excreted by the
liver and then reabsorbed. The ability of the deconvolu-
tion techniques to identify this second component using
noisy data presents a difficult challenge.
Figure 15 compares the deconvolution calculation of the
intestinal absorption (black) versus the actual model in-
put (green) for the four deconvolution methods using the
exact venous concentration data. The "gamma distribu-
tion" fit is poor because it assumes that the input can be
described by a single gamma distribution. The fits for the
other 3 methods are very good. The "spline function"
(bottom row, left) and "uniform" (bottom row, right) de-
convolution methods use the default input parameters
(smoothing and breakpoints) determined using the
gamma distribution fit to this data (top row, left) (see
Methods). As described above, for the analytical approach
the smoothing parameter must be adjusted by the user for
each experimental situation to determine the "best" fit. In
fig. 18, for this exact data, a smoothing parameter = 0 is
used, corresponding to the interpolating spline fit. The
total amount of absorption determined using the 4
methods is (actual input = 1.2): gamma distribution,
1.16; analytical, 1.203; spline, 1.204; and uniform, 1.199.
Each column in figure 16 compares the results of the 3
general deconvolution methods applied to same 3 sets of
"noisy" data (rows). As before, the noisy data is generated
by applying eq. (7) to each exact venous data point c [i],
with R [i] and Noise [i] normally distributed random
variables with a mean of 0 and standard deviations of 0.1
(corresponding to 10% of the absolute value) and 0.05
millimoles/liter, respectively. For the results in this figure
it is assumed that the user has no a priori information
about the correct value and, therefore, is required to use
the previously determined default values for the user in-
put parameters. For the analytical deconvolution, this is a
smoothing parameter of 1. For the spline and uniform
methods, this corresponds to the default value deter-
mined (see Methods) using the gamma input function for
this same noisy data set. All 3 methods indicate, qualita-
tively, that there is a second component. Overall, the
spline function method seems to be superior, at least for
inputs with this time course.BMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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Figure 14
Evaluation of the "uniform" deconvolution method for "noisy" data. Same as figure 11 except that the "uniform" deconvolution 
method was used.
Noisy #1
Noisy #2
Noisy #3
Model Gamma Uniform
Uniform Deconvolution - Exact and Noisy Data
Exact DataBMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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Figure 15
Evaluation of deconvolution methods for two component intestinal input with exact data. The green line is the composite 
intestinal input to the PBPK model consisting of the same gamma input used in figs. 9 to 14, plus a second, smaller, delayed 
gamma input. The black line is the intestinal input determined by application of the four deconvolution methods to the exact 
venous concentration data. The "spline" and "uniform" deconvolution methods use the "default" input parameters and the "ana-
lytical" method uses a smoothing parameter of 0.
Gamma Input
Analytical
Spline
Uniform
Two Component Input - Exact Data
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Figure 16
Evaluation of deconvolution methods for two component intestinal input with "noisy" data. Same as figure 15 except that a ran-
dom error was added to the venous concentration data. Each column corresponds to a different deconvolution method and 
each row to a different set of "noisy" data. The default parameters were used for all 3 deconvolution methods.
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Discussion and Conclusions
Use of a PBPK Model to Evaluate the Accuracy of the Bo-
lus Input Function r(t)
For the "simple" PBPK model in which the solute distrib-
utes in all the cell water with no binding, the bolus re-
sponse function is accurately described by a simple two
exponential function (fig. 2). The average fractional error
for the data in the right column of fig. 2 is 0.013, an error
that would certainly be swamped by experimental error.
This result is consistent with the fact that a 2-exponential
function is used in most of the recent experimental
applications of deconvolution [18,33,34]. For the more
"complicated" pharmacokinetic PBPK model where there
is extensive tissue binding (similar to that for pro-
pranolol), a 2-exponential function fit is no longer ade-
quate (fig. 4, right column, average fractional error = .041)
while a 3 exponential function provides a nearly perfect fit
(fig. 6, right column, average fractional error = 0.0024). It
is surprising that the complicated 11-compartment PBPK
pharmacokinetics can be fit with this degree of accuracy
using a 2 or 3-exponential function.
Although it seems obvious that one should try to make
the venous concentration measurements as early as
possible in order to accurately determine the bolus
response function, the results shown in figs. 2,3,4,5,6,7,8
provide the first quantitative analysis of this relationship.
Based on the results for the 10 minute (fig. 7, right col-
umn) and 30 minute (fig. 8) constant infusion, the fol-
lowing simple rule can be inferred: an accurate
determination of the response function requires that the
first sample point be obtained at or before the end of the
constant infusion. Intuitively, one might assume that a
true bolus IV injection should provide the best estimate of
the bolus response function. However, this is not correct
because of the unavoidable circulatory and mixing and
time delays which make venous concentration measure-
ments for time points earlier than 2 or 3 minutes unrelia-
ble. For this reason, a relatively long constant infusion
(e.g. 10 minutes) is superior to a bolus infusion. This is
best illustrated by comparing the left hand column if fig.
6 with the right hand column in fig. 7: the 30-second in-
fusion with the first data point as early as 2.5 minutes
does not provide as accurate an estimate of r(t) as the 10-
minute infusion with the first data point at 10 minutes.
In the experimental application of the deconvolution
method it is a common procedure to evaluate the accuracy
of the bolus response function r(t) by comparing the
venous concentration determined from r(t) with the actu-
al experimental venous concentration data. This analysis
shows that this may not be a reliable procedure. For exam-
ple, as shown in the left column of fig. 7, there is a large
error in the bolus response function (and the
corresponding calculation of the input function) deter-
mined using the 30-second input even though the re-
sponse function provides a nearly perfect fit to the discrete
model data. This error results from the very poor fit to the
venous concentration at times preceding the first data
point at 10 minutes.
Comparison of the Four Deconvolution Methods
Figures 9,10,11,12,13,14,15,16 quantitatively compare
the accuracy of the intestinal input determined by decon-
volution with the actual model input. Any differences in
these two input rates must be the result of errors in the
deconvolution process since the bolus response function
that is used in these calculations provides a nearly perfect
description of the system pharmacokinetics (see fig. 6,
right column). As shown in fig. 1, the 3-parameter gamma
distribution provides a versatile and accurate description
of a number of different intestinal input functions. One
would expect that, in most cases, intestinal absorption
(and absorption from skin, intramuscular and intraperito-
neal) could be approximated by a gamma distribution.
For these cases the gamma distribution deconvolution is
obviously the method of choice because it has only 3 ad-
justable parameters and the fitting process averages out
most of the error in "noisy" data (fig. 9). Another major
advantage of the gamma distribution approach is that
there are no user adjustable input parameters (e.g.
smoothing parameter), eliminating any user bias.
If the input cannot be described by a single gamma distri-
bution then one of the other three, more general, decon-
volution approaches must be used (i.e. "analytical",
"spline" and "uniform"). All three of these methods can,
potentially, provide a nearly perfect fit to the absorption
rate if the exact venous concentration data is used (figs.
10, 12, 14). An important qualification of this statement
is that this nearly perfect fit depends on the right choice of
the user input parameters. All 3 methods are dependent
on the "smoothing" parameter that limits the "roughness"
of the absorption rate. In addition, the "spline"
deconvolution method is strongly dependent on the
choice of "breakpoints" (see fig. 12). An important
criterion for evaluating the different methods is whether
the "best" value of the parameters can be determined ob-
jectively, without any user bias. Verotta [4] and De Nico-
lao et. al. [1] discuss a number of different criteria for
choosing these parameters, including the Akaike criterion
[35] and the "Generalized Cross Validation" [36]. Howev-
er, all of these criteria are semi-empirical and the different
criteria yield different "best" values. In addition, in order
to apply these criteria, the deconvolutions must be run
many times, greatly increasing the time of the
calculations.
A new approach for determining these user parameters for
the "spline" and "uniform" deconvolution methods is in-BMC Clinical Pharmacology 2003, 3 http://www.biomedcentral.com/1472-6904/3/1
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troduced in this paper. A "default" set of parameters is de-
termined without any user input, based on the
assumption that the input function can be roughly ap-
proximated by a gamma distribution. This new approach
works well for the single gamma distribution input case,
with these "default" parameters providing "best" fits for
both the exact and noisy data sets (figs. 14,15,16). It is,
perhaps, not surprising that it works for this case since the
input is close to a gamma distribution. A more
discriminating test of this approach is for the two input
case, when a second, smaller, delayed gamma distribution
is added. Although this input differs significantly from a
single gamma input (fig. 18, top left) this approach for
choosing the input parameters still provided good fits for
the exact (fig. 15) and noisy (fig. 16) data sets for the
"spline" and "uniform" approach. Of course, if the input
function has no relation to a gamma distribution, one
would expect this method to breakdown. However, most
physiological intestinal, skin, intramuscular or intraperi-
toneal absorption processes should resemble a gamma
distribution and this method should be applicable.
As discussed in the background section, the "analytical"
deconvolution method of Veng-Pedersen [6] is the most
commonly used experimental approach. It has the advan-
tage that is the fastest of the different methods and for
exact data it provides a good estimate of the absorption
rate (fig. 10). However, this method has 2 major handi-
caps. The first is that it is strongly dependent on the value
chosen for the "smoothing" parameter and there is no
direct technique that can be used to objectively determine
this parameter. Even knowing the standard deviation of
the experimental data (which is rarely the case) is not
enough to determine the "best" value of this parameter. As
shown in fig 11 for three different sets of noisy data, all
generated using the same random error parameters (eq.
(7)), the "best" fit has smoothing parameters varying from
0.1 (middle column) to 3 (left column). The second prob-
lem is that for the noisy data sets tested here (fig. 11) this
method provides fits to the absorption rate that, subjec-
tively, seem inferior to those determined by the other two
general deconvolution approaches ("spline" and "uni-
form"). Also, unlike the other approaches, the analytical
approach cannot be constrained from reaching non-phys-
ical negative values for the absorption rate (fig. 11).
Comprehensive quantitative evaluations of different de-
convolution approaches have been described previously
[7,11,22]. The evaluation in this paper is not comprehen-
sive, using a single typical human bolus response function
and just two different input functions (one and two com-
ponent) that are representative of human intestinal ab-
sorption rates. For this reason, the above conclusions
about the relative merits of the different methods are quite
limited. A major advantage of having the four methods
and the PBPK model available in a single, user friendly,
software package is that it allows other investigators to
carry out similar evaluations using their particular input
and response functions.
All of the procedures described in the paper are imple-
mented in PKQuest (freely distributed at http://
www.pkquest.com). This software routine has a simple
user interface and the output is displayed in a series of
graphical plots, some of which are illustrated by the fig-
ures in this paper.
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